• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Philip Morris International acquires OtiTopic expresspharma
    August 11, 2021
    This acquisition is part of PMI's strategic plan to leverage its expertise, scientific know-how and capabilities in inhalation to grow a pipeline of inhaled therapeutics and respiratory drug delivery Beyond Nicotine.
  • Philip Morris Heats Up Race for Vectura With $1.4 Billion Bid firstwordpharma
    August 09, 2021
    Philip Morris International on Sunday bid £1.65 per share for Vectura Group, after Carlyle on Friday offered £1.50 per share, Bloomberg reported.
  • Philip Morris agrees to acquire Vectura for $1.45bn pharmaceutical-technology
    July 13, 2021
    Philip Morris International (PMI) has made an offer to acquire a contract development and manufacturing organisation (CDMO), Vectura Group, for approximately $1.45bn (£1.045bn) to boost its product pipeline development expertise in inhaled treatments.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service